Charles Schwab’s Outlook Therapeutics OTLK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-36,060
Closed -$44K 3548
2025
Q1
$44K Buy
36,060
+12
+0% +$21 ﹤0.01% 3415
2024
Q4
$68.1K Sell
36,048
-15,411
-30% -$63.4K ﹤0.01% 3424
2024
Q3
$275K Buy
51,459
+18,287
+55% +$134K ﹤0.01% 3302
2024
Q2
$245K Buy
33,172
+15,442
+87% +$124K ﹤0.01% 3411
2024
Q1
$212K Sell
17,730
-1
-0% -$8 ﹤0.01% 3230
2023
Q4
$140K Hold
17,731
﹤0.01% 3319
2023
Q3
$78.4K Sell
17,731
-3,125
-15% -$69.1K ﹤0.01% 3373
2023
Q2
$726K Buy
20,856
+242
+1% +$6.6K ﹤0.01% 2885
2023
Q1
$449K Buy
20,614
+4,151
+25% +$92.9K ﹤0.01% 2984
2022
Q4
$356K Hold
16,463
﹤0.01% 3077
2022
Q3
$402K Sell
16,463
-86
-0.5% -$2K ﹤0.01% 3064
2022
Q2
$338K Buy
16,549
+714
+5% +$20.5K ﹤0.01% 3175
2022
Q1
$564K Buy
15,835
+4,832
+44% +$151K ﹤0.01% 3066
2021
Q4
$300K Hold
11,003
﹤0.01% 3285
2021
Q3
$478K Hold
11,003
﹤0.01% 3163
2021
Q2
$548K Buy
11,003
+9,281
+539% +$431K ﹤0.01% 3139
2021
Q1
$78K Buy
+1,722
New +$65.9K ﹤0.01% 3400

Other funds holding OTLK